{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:15Z","timestamp":1786119555050,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/coc.0b013e3181e84634","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T07:36:10Z","timestamp":1285054570000},"page":"395-400","source":"Crossref","is-referenced-by-count":18,"title":["Impact of Epidermal Growth Factor Receptor Expression on Disease-Free Survival and Rate of Pelvic Relapse in Patients With Advanced Cancer of the Cervix Treated With Chemoradiotherapy"],"prefix":"10.1097","volume":"34","author":[{"given":"Jos\u00e9","family":"P\u00e9rez-Regadera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"S\u00e1nchez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"De-la-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ballest\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Sotoca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"P\u00e9rez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lanz\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M","article-title":"Estimates of the worldwide mortality from 25 cancers in 1990.","volume":"83","author":"Pisan","year":"1999","journal-title":"Int J Cancer"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer.","volume":"361","author":"Waggoner","year":"2003","journal-title":"Lancet"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90\u201301.","volume":"22","author":"Eifel","year":"2004","journal-title":"J Clin Oncol"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.","volume":"349","author":"Rose","year":"1999","journal-title":"N Eng J Med"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxiurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group Study.","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant histerectomy for bulky stage IB cervical carcinoma.","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage carcinoma of the cervix.","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199904153401509","article-title":"Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy.","volume":"340","author":"Thomas","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1200\/JCO.2002.20.4.966","article-title":"Phase III trial comparing concurrent radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.","volume":"20","author":"Pearcey","year":"2002","journal-title":"J Clin Oncol"},{"key":"R10-10-20210128","first-page":"27","article-title":"Histopathologic prognostic factors in early stage cervical carcinoma.","volume":"21","author":"Benda","year":"1996","journal-title":"Monogr Natl Cancer Inst"},{"key":"R11-10-20210128","first-page":"455","article-title":"Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix.","volume":"23","author":"Tanaka","year":"1984","journal-title":"Acta Radiol"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","article-title":"Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.","volume":"38","author":"Delgado","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network.","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"suppl 4","key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.7-suppl_4-31","article-title":"Epidermal growth factor dependence in human tumors: more than just expression?","volume":"7","author":"Arteaga","year":"2002","journal-title":"The Oncologist"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor related peptides and their receptors in human malignancies.","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit Rev Oncol Hematol"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-8258(89)90540-4","article-title":"Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix.","volume":"33","author":"Pfeiffer","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jcp.46.2.149","article-title":"Prognostic value of epidermal growth factor receptor in cervical carcinoma.","volume":"46","author":"Hale","year":"1993","journal-title":"J Clin Pathol"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<433::AID-CNCR9>3.0.CO;2-K","article-title":"Evaluation of the prognosis significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma.","volume":"78","author":"Kristensen","year":"1996","journal-title":"Cancer"},{"key":"R19-10-20210128","first-page":"577","article-title":"Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.","volume":"5","author":"Kersermaekers","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/gyno.2002.6803","article-title":"Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma.","volume":"87","author":"Kim","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0360-3016(03)00209-8","article-title":"Epidermal growth factor and vascular endothelial growth factor negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.","volume":"4","author":"Gaffney","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ygyno.2004.01.006","article-title":"Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.","volume":"93","author":"Lee","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0090-8258(91)90107-G","article-title":"Expression of ras oncogen product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement.","volume":"40","author":"Hayashi","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1525-1438.1997.00431.x","article-title":"Expression of cathepsin D and epidermal growth factor in stage III cervical carcinomas.","volume":"7","author":"Oka","year":"1997","journal-title":"Int J Gynecol Cancer"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(97)00421-7","article-title":"Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer.","volume":"123","author":"Scambia","year":"1998","journal-title":"Cancer Lett"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000050613","article-title":"Abnormal expression of the epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis.","volume":"22","author":"Ngan","year":"2001","journal-title":"Tumor Biol"},{"key":"R27-10-20210128","first-page":"493","article-title":"Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.","volume":"44","author":"Hove","year":"1999","journal-title":"J Reprod Med"},{"key":"R28-10-20210128","first-page":"551","article-title":"Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.","volume":"7","author":"Nagai","year":"2000","journal-title":"Oncol Rep"},{"key":"R29-10-20210128","article-title":"NCI Clinical Announcement.","year":"1999"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1520-6823(1997)5:4<180::AID-ROI3>3.0.CO;2-U","article-title":"Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck.","volume":"5","author":"Sheridan","year":"1997","journal-title":"Radiat Oncol Investig"},{"key":"R31-10-20210128","first-page":"2884","article-title":"Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas.","volume":"5","author":"Akimoto","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2004.12.021","article-title":"The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis.","volume":"74","author":"Giralt","year":"2005","journal-title":"Radiother Oncol"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/gyno.1996.0039","article-title":"Expression of epidermal growth factor receptor in carcinoma of the cervix.","volume":"60","author":"Kim","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R34-10-20210128","first-page":"79","article-title":"Age as a prognostic factor in cancer of the cervix: the UAMS experience.","volume":"89","author":"Bolli","year":"1992","journal-title":"J Ark Med Soc"},{"key":"R35-10-20210128","first-page":"19","article-title":"A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and\/or 5-fluorouracil for the treatment of locally advanced cervical cancer.","volume":"92","author":"Borowsky","year":"2005","journal-title":"Bull Cancer"},{"key":"R36-10-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-8140(95)01535-O","article-title":"Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis.","volume":"35","author":"Fyles","year":"1995","journal-title":"Radiother Oncol"},{"key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s002800000239","article-title":"Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines.","volume":"47","author":"Ling","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3B","key":"R38-10-20210128","first-page":"2577","article-title":"Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.","volume":"23","author":"Knecht","year":"2003","journal-title":"Anticancer Res"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0b013e3181e84634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:00Z","timestamp":1786041300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201108000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e3181e84634","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}